{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:34:26Z","timestamp":1790357666226,"version":"4.1.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,22]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim is to explore the roles of phosphorylated signal transduction and activator of transcription 3 (p-STAT3) and interleukin (IL)-17 in patients with dermatomyositis (DM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 20 DM patients and 12 healthy controls were enrolled. Flow cytometry combined with counting was used to detect the number of Th17 cells. Western blotting and immunohistochemistry were used to examine the muscle levels of p-STAT3 and IL-17, and serum levels of IL-17 were measured by enzyme-linked immunosorbent assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Muscle p-STAT3 and IL-17 levels, the number of Th17 cells, and serum IL-17 levels were markedly increased in DM. p-STAT3 and IL-17 were co-expressed in the muscle of DM patients. The p-STAT3 levels were correlated with the number of Th17 cells as well as muscle and serum IL-17 levels. The correlations of the p-STAT3 level with elevated levels of transaminases, myocardial enzymes, and the health assessment questionnaire score were significantly positive, while the correlation with manual muscle testing-8 was significantly negative. A receiver operating characteristic curve indicated the good predictive value of p-STAT3 for the occurrence of DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The increased p-STAT3\/IL-17 signaling pathway activation in DM patients may induce muscle inflammation and necrosis, and it may be a potential target for DM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/mr\/roac147","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T07:34:25Z","timestamp":1670484865000},"page":"129-136","source":"Crossref","is-referenced-by-count":7,"title":["Increased expression of the p-STAT3\/IL-17 signaling pathway in patients with dermatomyositis"],"prefix":"10.1093","volume":"34","author":[{"given":"Dongmei","family":"Li","sequence":"first","affiliation":[{"name":"Department of Rheumatology, The First Hospital of Shanxi Medical University , Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First Hospital of Shanxi Medical University , Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First Hospital of Shanxi Medical University , Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First Hospital of Shanxi Medical University , Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First Hospital of Shanxi Medical University , Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First Hospital of Shanxi Medical University , Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First Hospital of Shanxi Medical University , Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongping","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First Hospital of Shanxi Medical University , Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4888-9876","authenticated-orcid":false,"given":"Zili","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First Hospital of Shanxi Medical University , Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"2023122314261592100_R1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","article-title":"239th ENMC International Workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018","volume":"30","author":"Mammen","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"2023122314261592100_R2","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1093\/rheumatology\/keaa661","article-title":"Persistent premature mortality gap in dermatomyositis and polymyositis: a United Kingdom general population-based cohort study","volume":"60","author":"D\u2019Silva","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023122314261592100_R3","first-page":"623","article-title":"Mortality in patients with polymyositis and dermatomyositis in an Israeli population","volume":"22","author":"Kridin","year":"2020","journal-title":"Isr Med Assoc J"},{"key":"2023122314261592100_R4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/1756-185X.14128","article-title":"Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy","volume":"24","author":"Bai","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"2023122314261592100_R5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12016-016-8527-x","article-title":"The immune response and the pathogenesis of idiopathic inflammatory myositis: a critical review","volume":"52","author":"Ceribelli","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"2023122314261592100_R6","doi-asserted-by":"crossref","first-page":"S460","DOI":"10.1067\/mai.2003.108","article-title":"2. Cytokines and chemokines","volume":"111","author":"Borish","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"2023122314261592100_R7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/815245","article-title":"IL-6, IL-8, and IL-10 are associated with hyperferritinemia in rapidly progressive interstitial lung disease with polymyositis\/dermatomyositis","volume":"2014","author":"Kawasumi","year":"2014","journal-title":"Biomed Res International"},{"key":"2023122314261592100_R8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/03009742.2014.956141","article-title":"Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies","volume":"44","author":"Notarnicola","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"2023122314261592100_R9","first-page":"194","article-title":"Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies","volume":"59","author":"Wilkinson","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2023122314261592100_R10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/intimm\/dxm045","article-title":"IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state","volume":"19","author":"Nishihara","year":"2007","journal-title":"Int Immunol"},{"key":"2023122314261592100_R11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.immuni.2008.07.018","article-title":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction","volume":"29","author":"Ogura","year":"2008","journal-title":"Immunity"},{"key":"2023122314261592100_R12","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2741\/4054","article-title":"IL-6, IL-17 and STAT3: a holy trinity in auto-immunity","volume":"17","author":"Camporeale","year":"2012","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2023122314261592100_R13","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1159\/000484390","article-title":"IL-17 activates the IL-6\/STAT3 signal pathway in the proliferation of hepatitis B virus-related hepatocellular carcinoma","volume":"43","author":"Hu","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"2023122314261592100_R14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111922","article-title":"Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: where are we and where should we go?","volume":"187","author":"Huang","year":"2020","journal-title":"Eur J Med Chem"},{"key":"2023122314261592100_R15","first-page":"1","article-title":"Hmgb1-IL-23-IL-17-IL-6-Stat3 axis promotes tumor growth in murine models of melanoma","volume":"2013","author":"Tang","year":"2013","journal-title":"Mediators Inflamm"},{"key":"2023122314261592100_R16","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1038\/onc.2014.286","article-title":"Th17-type cytokines, IL-6 and TNF-\u03b1 synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth","volume":"34","author":"De Simone","year":"2015","journal-title":"Oncogene"},{"key":"2023122314261592100_R17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/605208","article-title":"Allicin alleviates dextran sodium sulfate-(DSS-) induced ulcerative colitis in BALB\/c mice","volume":"2015","author":"Pandurangan","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"2023122314261592100_R18","first-page":"1","article-title":"Yangyin Qingre Huoxue method in traditional Chinese medicine ameliorates atherosclerosis in ApoE-\/- mice suffering from high-fat diet and HSP65 aggression","volume":"2019","author":"Qiu","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"2023122314261592100_R19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20035","article-title":"Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies","volume":"62","author":"Rider","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023122314261592100_R20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.nmd.2016.05.014","article-title":"213th ENMC International Workshop: outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015","volume":"26","author":"Benveniste","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"2023122314261592100_R21","first-page":"424","article-title":"p-STAT3 in luminal breast cancer: integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial","volume":"52","author":"Sonnenblick","year":"2018","journal-title":"Int J Oncol"},{"key":"2023122314261592100_R22","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O\u2019Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"key":"2023122314261592100_R23","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"2023122314261592100_R24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"2023122314261592100_R25","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.90100.2007","article-title":"Muscle as an endocrine organ: focus on muscle-derived interleukin-6","volume":"88","author":"Pedersen","year":"2008","journal-title":"Physiol Rev"},{"key":"2023122314261592100_R26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-5728(03)00032-8","article-title":"Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis","volume":"137","author":"Chevrel","year":"2003","journal-title":"J Neuroimmunol"},{"key":"2023122314261592100_R27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cyto.2006.05.009","article-title":"Immunization of mice with T cell-dependent antigens promotes IL-6 and TNF-alpha production in muscle cells","volume":"35","author":"T\u00fcz\u00fcn","year":"2006","journal-title":"Cytokine"},{"key":"2023122314261592100_R28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.21873\/invivo.11108","article-title":"Elevated IL-4 and IFN-\u03b3 levels in muscle tissue of patients with dermatomyositis","volume":"31","author":"Giri\u015f","year":"2017","journal-title":"In Vivo (Brooklyn)"},{"key":"2023122314261592100_R29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009742.2010.517215","article-title":"Interleukin-17 and interleukin-23 in patients with polymyositis and dermatomyositis","volume":"40","author":"Shen","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"2023122314261592100_R30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4081\/reumatismo.2014.746","article-title":"Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies","volume":"66","author":"Notarnicola","year":"2014","journal-title":"Reumatismo"},{"key":"2023122314261592100_R31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3899\/jrheum.160293","article-title":"Gene expression profiling in blood and affected muscle tissues reveals differential activation pathways in patients with new-onset juvenile and adult dermatomyositis","volume":"44","author":"L\u00f3pez De Padilla","year":"2017","journal-title":"J Rheumatol"},{"key":"2023122314261592100_R32","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/art.27465","article-title":"Expression of toll-like receptor 3 and toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines","volume":"62","author":"Tournadre","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2023122314261592100_R33","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-021-02140-2","article-title":"NF-kB-dependent activation of STAT3 by H. pylori is suppressed by TFF1","volume":"21","author":"Soutto","year":"2021","journal-title":"Cancer Cell Int"},{"key":"2023122314261592100_R34","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.4103\/0366-6999.213419","article-title":"Upregulation of interleukin 21 and interleukin 21 receptor in patients with dermatomyositis and polymyositis","volume":"130","author":"Liu","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"2023122314261592100_R35","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/rheumatology\/keu005","article-title":"Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity","volume":"53","author":"Ciccia","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2023122314261592100_R36","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/BOR.0000000000000831","article-title":"Lymphocyte immunophenotyping in inflammatory myositis: a review","volume":"33","author":"Franco","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"2023122314261592100_R37","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol Cancer"},{"key":"2023122314261592100_R38","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1089\/jir.2019.0063","article-title":"Interleukin-35: a serological biomarker for patients with polymyositis\/dermatomyositis","volume":"39","author":"Jiang","year":"2019","journal-title":"J Interferon Cytokine Res"},{"key":"2023122314261592100_R39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/eji.201646723","article-title":"IL-17 and IL-22 in immunity: driving protection and pathology","volume":"47","author":"Eyerich","year":"2017","journal-title":"Eur J Immunol"},{"key":"2023122314261592100_R40","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"2023122314261592100_R41","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/ni.3742","article-title":"Interleukin 17 is a chief orchestrator of immunity","volume":"18","author":"Veldhoen","year":"2017","journal-title":"Nat Immunol"},{"key":"2023122314261592100_R42","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.4049\/jimmunol.1201505","article-title":"Keratinocyte expression of IL-17C promotes psoriasiform skin inflammation","volume":"190","author":"Johnston","year":"2013","journal-title":"J Immunol"},{"key":"2023122314261592100_R43","doi-asserted-by":"crossref","first-page":"113360","DOI":"10.18632\/oncotarget.23008","article-title":"The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1\/2 pathway","volume":"8","author":"Laprevotte","year":"2017","journal-title":"Oncotarget"},{"key":"2023122314261592100_R44","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.celrep.2016.07.075","article-title":"Nrf2 Induces IL-17D to mediate tumor and virus surveillance","volume":"16","author":"Saddawi-Konefka","year":"2016","journal-title":"Cell Rep"},{"key":"2023122314261592100_R45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009124","article-title":"Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation","volume":"6","author":"Beale","year":"2014","journal-title":"Sci Transl Med"},{"key":"2023122314261592100_R46","doi-asserted-by":"crossref","DOI":"10.1186\/s41927-020-00150-7","article-title":"Serum protein biomarkers for juvenile dermatomyositis: a pilot study","volume":"4","author":"Tawalbeh","year":"2020","journal-title":"BMC Rheumatol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roac147\/48423546\/roac147.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/34\/1\/129\/54800220\/roac147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/34\/1\/129\/54800220\/roac147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T09:27:28Z","timestamp":1703323648000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/34\/1\/129\/6883873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,8]]},"published-print":{"date-parts":[[2023,12,22]]}},"URL":"https:\/\/doi.org\/10.1093\/mr\/roac147","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2022,12,8]]}}}